These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36997589)

  • 21. Tissue inhibitors of metalloproteinases are proteolytic targets of matrix metalloproteinase 9.
    Coates-Park S; Lazaroff C; Gurung S; Rich J; Colladay A; O'Neill M; Butler GS; Overall CM; Stetler-Stevenson WG; Peeney D
    Matrix Biol; 2023 Nov; 123():59-70. PubMed ID: 37804930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin-II induced hypertension and renovascular remodelling in tissue inhibitor of metalloproteinase 2 knockout mice.
    Pushpakumar S; Kundu S; Pryor T; Givvimani S; Lederer E; Tyagi SC; Sen U
    J Hypertens; 2013 Nov; 31(11):2270-81; discussion 2281. PubMed ID: 24077247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats].
    Chen RQ; Chen XM; Cui SW; Cai GY; Shi SZ; Xie YS; Lu Y; Peng LX
    Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):937-42. PubMed ID: 15329283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Engineering minimal tissue inhibitors of metalloproteinase targeting MMPs via gene shuffling and yeast surface display.
    Hosseini A; Kumar S; Hedin K; Raeeszadeh-Sarmazdeh M
    Protein Sci; 2023 Dec; 32(12):e4795. PubMed ID: 37807423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
    Bigg HF; Morrison CJ; Butler GS; Bogoyevitch MA; Wang Z; Soloway PD; Overall CM
    Cancer Res; 2001 May; 61(9):3610-8. PubMed ID: 11325829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Matrix metalloproteases and their inhibitors are produced by overlapping populations of activated astrocytes.
    Muir EM; Adcock KH; Morgenstern DA; Clayton R; von Stillfried N; Rhodes K; Ellis C; Fawcett JW; Rogers JH
    Brain Res Mol Brain Res; 2002 Apr; 100(1-2):103-17. PubMed ID: 12008026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amlodipine and Atorvastatin Improved Hypertensive Cardiac Remodeling through Regulation of MMPs/TIMPs in SHR Rats.
    Lu J; Hao J; Du H; Xiao B; Li Y; Yang X; Cui W
    Cell Physiol Biochem; 2016; 39(1):47-60. PubMed ID: 27322513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases by Porphyromonas gingivalis in an engineered human oral mucosa model.
    Andrian E; Mostefaoui Y; Rouabhia M; Grenier D
    J Cell Physiol; 2007 Apr; 211(1):56-62. PubMed ID: 17226791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of mRNAs encoding MMP-9 and MMP-2, and their inhibitors TIMP-1 and TIMP-2 by androgens in the rat ventral prostate.
    Limaye AM; Desai KV; Chavalmane AK; Kondaiah P
    Mol Cell Endocrinol; 2008 Nov; 294(1-2):10-8. PubMed ID: 18675881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Imbalance of MMP-2/TIMP-2 and MMP-9/TIMP-1 Contributes to Collagen Deposition Disorder in Diabetic Non-Injured Skin.
    Zhou P; Yang C; Zhang S; Ke ZX; Chen DX; Li YQ; Li Q
    Front Endocrinol (Lausanne); 2021; 12():734485. PubMed ID: 34777244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dynamic expression of mRNAs and proteins for matrix metalloproteinases and their tissue inhibitors in the primate corpus luteum during the menstrual cycle.
    Young KA; Hennebold JD; Stouffer RL
    Mol Hum Reprod; 2002 Sep; 8(9):833-40. PubMed ID: 12200461
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of gelatinases (MMP-2 and MMP-9) and tissue inhibitors of metalloproteinases (TIMP-2 and TIMP-3) in the chicken ovary in relation to follicle development and atresia.
    Hrabia A; Wolak D; Kwaśniewska M; Kieronska A; Socha JK; Sechman A
    Theriogenology; 2019 Feb; 125():268-276. PubMed ID: 30481606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of matrix metalloproteinases and their inhibitors during hepatic tissue repair in the rat.
    Knittel T; Mehde M; Grundmann A; Saile B; Scharf JG; Ramadori G
    Histochem Cell Biol; 2000 Jun; 113(6):443-53. PubMed ID: 10933221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene Expression of Matrix Metalloproteinases and their Inhibitors (TIMPs) in Meningiomas of Dogs.
    Mandara MT; Reginato A; Foiani G; De Luca S; Guelfi G
    J Vet Intern Med; 2017 Nov; 31(6):1816-1821. PubMed ID: 28875568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic polymorphisms of matrix metalloproteinases and their inhibitors in potentially malignant and malignant lesions of the head and neck.
    Chaudhary AK; Singh M; Bharti AC; Asotra K; Sundaram S; Mehrotra R
    J Biomed Sci; 2010 Feb; 17(1):10. PubMed ID: 20152059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases.
    Cabral-Pacheco GA; Garza-Veloz I; Castruita-De la Rosa C; Ramirez-Acuña JM; Perez-Romero BA; Guerrero-Rodriguez JF; Martinez-Avila N; Martinez-Fierro ML
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33419373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Designing TIMP (tissue inhibitor of metalloproteinases) variants that are selective metalloproteinase inhibitors.
    Nagase H; Brew K
    Biochem Soc Symp; 2003; (70):201-12. PubMed ID: 14587293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metalloproteinase and tissue inhibitor of metalloproteinase expression in the murine STR/ort model of osteoarthritis.
    Flannelly J; Chambers MG; Dudhia J; Hembry RM; Murphy G; Mason RM; Bayliss MT
    Osteoarthritis Cartilage; 2002 Sep; 10(9):722-33. PubMed ID: 12202125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of High Affinity and High Specificity Inhibitors of Matrix Metalloproteinase 14 through Computational Design and Directed Evolution.
    Arkadash V; Yosef G; Shirian J; Cohen I; Horev Y; Grossman M; Sagi I; Radisky ES; Shifman JM; Papo N
    J Biol Chem; 2017 Feb; 292(8):3481-3495. PubMed ID: 28087697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinase 1 and 2 in inflammation-induced corneal neovascularization.
    Ma DH; Chen JK; Kim WS; Hao YX; Wu HC; Tsai RJ; Hwang DG; Zhang F
    Ophthalmic Res; 2001; 33(6):353-62. PubMed ID: 11721189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.